Clinical Validation of a Refined Lupus Disease Activity Index Informed by Immune Mediators that Characterizes Clinical and Serological Disease Activity In Systemic Lupus Erythematosus
Munroe M, Blankenship D, DeFreese D, Holloway A, Rubin B, Purushothaman M, DeJager W, Macwana S, Guthridge J, Redinger N, Aberle T, Arriens C, Li Y, Zeng H, Dezzutti S, Izmirly P, Manna Z, Thomas D, Valenzuela G, Perez K, Abinader A, Kivitz A, Hasni S, Thanarajasingam U, Kamen D, Buyon J, James J, Jupe E. Clinical Validation of a Refined Lupus Disease Activity Index Informed by Immune Mediators that Characterizes Clinical and Serological Disease Activity In Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 9)